Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Camzyos 5 mg hard capsules {equilateral_black_triangle}

Active Ingredient:
mavacamten
Company:  
Bristol Myers Squibb Pharmaceuticals limited See contact details
ATC code: 
C01EB24
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Camzyos (mavacamten) Healthcare Professional Cover Letter UK – Introduction of Additional Risk Minimisation Materials

{healthcare_pro_orange} For Healthcare Professionals
The risk minimisation materials for mavacamten were developed as a condition of the marketing authorisation for this product. These materials contain important safety information. Please refer to the attached letter for further information.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Bristol Myers Squibb Pharmaceuticals limited
Company image
Address
Bristol-Myers Squibb, ARC Uxbridge, Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH, UK
Telephone
+44 (0)1895 523 000
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0) 800 731 1736
Medical Information Website
https://www.bmsmedinfo.co.uk/